can you change from semaglutide to tirzepatide A Comprehensive Guide for Smooth Transition What Happens When You Switch

doi:10.1016/j.physbeh.2012.04.004

K., and Bourdette, D

They are also not recommended in individuals with certain conditions such as inflammatory bowel disease, pancreatitis, personal or family history of medullary thyroid cancer or multiple endocrine neoplasia

[1] The FDA label includes a boxed warning regarding thyroid C-cell tumors and contraindicates tirzepatide in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Section 503A of the Federal Food, Drug, and Cosmetic Act states a licensed pharmacist cannot compound regularly or in inordinate amounts